Educational and Informational Intervention for Advanced Cancer Parents
(EC-PC Trial)
Trial Summary
What is the purpose of this trial?
This trial examines the usefulness of two educational programs for parents with late-stage cancer who have a 5 - 17 year old child. The programs are designed to enhance the quality of the parent-child relationship and add to the parent's confidence in managing the impact of their cancer on their child. Educational programs may reduce anxiety and depression and improve the well-being and quality of life of parents with advanced cancers and their children. Recruitment occurs nationally via referral to the Fred Hutch/University of Washington Cancer Consortium team.
Do I need to stop my current medications to join the trial?
The trial does not specify whether you need to stop taking your current medications. All therapies are allowed, so you likely can continue your current treatment.
What data supports the effectiveness of the Educational and Informational Intervention for Advanced Cancer Parents treatment?
Is the Educational and Informational Intervention for Advanced Cancer Parents safe for humans?
How is the Educational and Informational Intervention for Advanced Cancer Parents treatment different from other treatments?
This treatment is unique because it focuses on providing educational and informational support to parents of children with advanced cancer, using a variety of teaching techniques like written materials, self-instructional exercises, and group discussions to enhance learning and emotional support, which is not typically the focus of standard medical treatments.1112131415
Research Team
Frances M Lewis, RN, MN, PhD, FAAN
Principal Investigator
University of Washington
Eligibility Criteria
This trial is for parents aged 23-68 with advanced, non-curable cancer who have a child between the ages of 5 and 17 living at home at least half the time. Participants must be able to read/write English, not be in hospice care, and have access to a phone. The non-ill co-parent must consent to participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the 5-session EC-PC program bi-weekly or educational materials with a phone call
Follow-up
Participants are monitored for safety and effectiveness after treatment
Long-term Follow-up
Effects of family environment and symptom burden on treatment outcomes are assessed
Treatment Details
Interventions
- Control group
- Educational Intervention
- Enhancing Connections Program
- Informational Intervention
- Questionnaire Administration
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor
National Institute of Nursing Research (NINR)
Collaborator